Tissue regeneration based on growth factor release

Tissue Engineering

Volumn 9, Issue SUPPL. 1, 2003, Pages

  Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; AGAROSE; ALGINIC ACID; AMYLOPECTIN; BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CHITOSAN; COLLAGEN; EPIDERMAL GROWTH FACTOR; ETHYLENE VINYL ACETATE COPOLYMER; GELATIN; GROWTH FACTOR; HEPARIN; HYDROXYAPATITE; MACROGOL; MICROSPHERE; NERVE GROWTH FACTOR; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; POLYGLACTIN; POLYLACTIC ACID; POLYVINYL ALCOHOL; SCATTER FACTOR; SOMATOMEDIN C; TITANIUM; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG DELIVERY SYSTEM; HUMAN; HYDROGEL; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 0041825765     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/10763270360696941     Document Type: Review

References (74)

1. Hay, E.D. ed., Cell Biology of Extracellular Matrix, 2nd Ed. New York: Plenum Press, 1991.
2. Heckman J.D., Boyan, B.D., Aufdemorte, T.B., et al. The use of bone morphogenetic protein in the treatment of nonunion in a canine model. J. Bone Joint Surg. 73, 750, 1991.
3. Takaoka, K., Nakahara, H., Koezuka, M., et al. Telopeptide-deleted bovine skin collagen as a carrier for bone morphogenetic protein. J. Orthop. Res. 9, 902, 1991.
4. Kuboki, Y., Sasaki, M., Saito, A., et al. Regeneration of periodontal ligament and cementum by BMP-applied tissue engineering. Eur. J. Oral Sci. 106, 197, 1998.
5. Urist, M.R., Lietze, A., and Dawson, E. β-Tricalcium phospate delivery system for bone morphogenetic protein. Clin. Orthop. 187, 277, 1984.
6. Ono, I., Ohura, T., Murata, M., et al. A study on bone indication in hydroxyapatite combined with bone morphogenetic protein. Plast. Reconstr. Surg. 90, 870, 1992.
7. Muschler, G.F., Hyodo, A., Manning, T., et al. Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin. Orthop. 308, 229, 1994.
8. Kenley, R., Marden, L., Turek, T., et al. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic proetin-2 (rhBMP-2). J. Biomed. Mater. Res. 28, 1139, 1994.
9. Zellin, G., and Linde, A. Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive mandibular defects. J. Biomed. Mater. Res. 35, 181, 1997.
10. Sigurdsson, T.J., Lee, M.B., Kubota, K., et al. Periodontal repairing in dogs: Recombinant bone morphogenetic protein-2 significantly enhances periodontal regeneration. J. Periodontol. 66, 131, 1995.
11. Liu Hong, L., Tabata, Y., Yamamoto, M., et al. Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution. J. Biomater. Sci. Polym. Ed. 9, 1001, 1998.
12. Miyamoto, S., Takaoka, K., Okada, T., et al. Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. Clin. Orthop. 278, 274, 1992.
13. Ripamonti, U., Ma, S.S., van der Heerver, B., et al. Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvaria defects of adult primates. Plast. Reconstr. Surg. 90, 382, 1992.
14. Miyamoto, S., Takaoka, K., Okada, T., et al. Polylactic acid-polyethylene glycol block copolymer: A new biodegradable synthetic carrier for bone morphogenetic protein. Clin. Orthop. 294, 333, 1994.
15. Cook, S.D., Dalton, J.E., Tan, T.E., et al. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone substitute for spinal fusion. Spine 19, 1655, 1994.
16. Cook, S.D., Baffes, G.C., Wolfe, M.W., et al. Recombinant bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin. Orthop. 301, 302, 1994.
17. Schreiber, A.B., et al. Transforming growth factor-α: A more potent angiogenic mediator than epithelial growth factor. Science 232, 1250, 1986.
18. Buckley, A., et al. Sustained release of epidermal growth factor accelerates wound healing. Proc. Natl. Acad. Sci. USA 82, 7340, 1985.
19. Fajardo, L.F., Kowalski, J., Kwan, H.H., et al. 1988. The disc angiogenesis system. Lab. Invest. 58, 718, 1985.
20. Downs, E.C., et al. Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro. J. Cell Physiol. 152, 422, 1992.
21. Edelman, E.R., Mathiowitz, E., Langer, R., et al. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 12, 619, 1991.
22. Harada, K., Grossman, W., Friedman, M., et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J. Clin. Invest. 94, 623, 1994.
23. Tabata, Y., Matsui, Y., and Ikada, Y. Growth factor release from amylopectin hydrogel based on copper coordination. J. Control. Release 56, 135, 1998.
24. Tabata, Y., Hijikata, S., and Ikada, Y. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J. Control. Release 31, 189, 1994.
25. Kawai, K., Suzuki, S., Tabata, Y., et al. Accelerated tissue regeneration through incorpoartion of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials 21, 489, 2000.
26. Tabata, Y., Miyao, M., Inamoto, T., et al. De novo formation of adipose tissue by controlled release of basic fibroblast growth factor. Tissue Eng. 6, 279, 2000.
27. Tabata, Y., Yamada, K., Miyamoto, S., et al. Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogel. Biomaterials 19, 807, 1998.
28. Tabata, Y., Yamada, K., Hong, L., et al. Skull bone regeneration in primates in response to basic fibroblast growth factor. J. Neurosurg. 91, 851, 1999.
29. Fujimoto, E., Mizoguchi, A., Handa, M., et al. Basic fibroblast growth factor promotes extension of regenerating axons of peripheral nerve: In vivo experiments using a Schwann cell basal lamina tube model. J. Neurocytol. 26, 522, 1997.
30. DeBlois, C., Cote, M.F., and Doillon, C.J. Heparin-fibroblast growth factor-fibrin complex: In vitro and in vivo applications to collagen-based materials. Biomaterials 15, 665, 1994.
31. Maeda, M., Sano, S., Fujioka, K., et al. Local sustained release formulation for fracture treatment, basic fibroblast growth factor minipellet. Proc. Int. Symp. Control. Release Bioact. Mater. 22, 494, 1995.
32. Fujisata, T., Sajiki, T., Liu, Q., et al. Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collagen sponge scaffold. Biomaterials 17, 155, 1996.
33. Aebischer, P., Salessiotis, A.N., and Winn, S.R. Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps. J. Neurosci. Res. 23, 282, 1989.
34. Yamamoto, S., Yoshimime, T., Fujita, T., et al. Protective effect of NGF ateocollagen minipellet on the hippocampal delayed neuronal death in gerbils. Neurosci. Lett. 23, 605, 1992.
35. Camarata, P.J., Suryanarayanan, R., Turner, D.A., et al. Sustianed release of nerve growth factor from biodegradable polymer microspheres. Neurosurgery 30, 313, 1992.
36. 1 depends on the topical delivery system. J. Surg. Res. 58, 321, 1995.
37. 1 incorporated into hydrogels with different levels of biodegradability. J. Neurosurg. 92, 315, 2000.
38. 1 released from polymeric and ceramic implants. J. Appl. Biomater. 5, 141, 1994.
39. 1 adsorbed to tricalciumphosphate coated implants increases peri-implant bone remodeling. Biomaterials 22, 189, 2001.
40. 1 absorbed on microcrystals of hydroxyapatite. Trans. Orthop. Res. Soc. 591, 23, 1992.
41. 1 in calvarial defects of adult baboons. J. Bone Miner. Res. 11, 938, 1996.
42. Mustoe, T.A., Pierce, G.F., Thomason, A., et al. Accelerated healing of incisional wounds in rats induced by transforming growth factor β. Science 237, 1333, 1987.
43. Arm, D.M., Tencer, A.F., Bain, S.D., et al. Effects of controlled release of platelet-derived growth factor from porous hydroxyapatite implant on bone ingrowth. Biomaterials 17, 703, 1996.
44. Khouri, R.K., et al. De novo generation of permanent neovascularized soft tissue appendages by platelet-derived growth factor. J. Clin. Invest. 94, 1757, 1994.
45. Park, Y.J., Lee, Y.M., Park, S.N., et al. Platelet derived growth factor releasing chitosan sponge for periodontal bone regeneration. Biomaterials 21, 153, 2000.
46. Tabata, Y., Miyao, M., Ozeki, M., et al. Controlled release of vascular endothelial growth factor released by use of collagen hydrogels. J. Biomater. Sci. Polym. Ed. 11, 915, 2000.
47. Peters, M.C., et al. Release from alginate enhances the biological activity of vascular endothelial growth factor. J. Biomater. Sci. Polym. Ed. 9, 1267, 1998.
48. Ozeki, M., Ishii, T., Hirano, Y., et al. Controlled release of hepatocyte growth factor from gelatin hydrogels based on hydrogel degradation. J. Drug Target. 9, 461, 2001.
49. Yuksel, E., Weinfeld, A.B., Cleek, R., et al. Augmentation of adipofascial flaps using the long-term local delivery of insulin and insulin-like growth factor I. Plast. Reconstr. Surg. 106, 373, 2000.
50. Yuksel, E., Weinfeld, A.B., Cleek, R., et al. Increased free fat-graft survival with the long-term, local delivery of isulin, insulin-like growth factor-I, and basic fibroblast growth factor by PLGA/PEG microspheres. Plast. Reconstr. Surg. 105, 1712, 2000.
51. Richardson, T.P., Oeters, M.C., Ennett, A.B., et al. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19, 1029, 2001.
52. Lynch, S.E., Buser D., Hernandez, R.A., et al. Effects of the platelet-derived growth factor/insulin-like growth factor-I combination on bone regeneration around titanium dental implant. Result of a pilot study in beagle dog. J. Periodontol. 62, 710, 1991.
53. Bonadio, J., Goldstein, S.A., and Lecy, R.J., Gene therapy for tissue repairing and regeneration. Adv. Drug Deliv. Rev. 33, 53, 1998.
54. Lee, J.S., and Feldman, A.M. Gene therapy for therapeutic myocardial andiogenesis: A promising synthesis of two emerging technologies. Nat. Med. 4, 739, 1998.
55. Schwarz, E.R., Speakmen, M.T., Patterson, M., et al. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat - angiogenesis and angioma formation. J. Am. Coll. Cardiol. 35, 1323, 2000.
56. Taniyama, Y., Morishita, R., Hiraoka, K., et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: Molecular mechanisms of delayed angiogenesis in diabetes. Circulation 104, 2344, 2001.
57. Kasahara, H., Tanaka, E., Fukuyama, N., Sato, E., et al. Biodegradable gelatin hydrogels potentiates the angiogenesis effect of FGF4 plasmid in rabbit hindlimb ischemia. J. Am. Coll. Cardiol. 41, 1056, 2003.
58. Bonadio, J., et al. Localized, directed plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue engineering. Nat. Med. 5, 753, 1999.
59. Simons, M., Bonow, R.O., Chronos, N.A., et al. Clinical trials in coronary angiogenesis: Issues, problems, consensus. Circulation 102, e73, 2000.
60. Park, K., Shakaby, H., and Park, H. Biodegradable Hydrogels for Drug Delivery. Lancaster, PA: Technomic Publishing, 1993.
61. Tabata, Y., and Ikada, Y. Protein release from gelatin matrices. Adv. Drug Deliv. Rev. 31, 287, 1998.
62. Tabata, Y., Nagano, A., and Ikada, Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng. 5, 127, 1999.
63. Tabata, Y., Hijikata, S., Munirzzaman, M., et al. Neovascularization through biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J. Biomater. Sci. Polym. Ed. 10, 79, 1999.
64. Tabata, Y., Morimoto, K., Katsumata, H., et al. Surfactant-free preparation of biodegradable hydrogel microspheres for protein release. J. Bioactive Compatible Polym. 14, 371, 1999.
65. Rifkin, D.B., and Moscatelli, D. Structural charcterization and biological functions of basic fibroblast growth factor. J. Cell Biol. 109, 1, 1989.
66. Tabata, Y., and Ikada, Y. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 20, 2169, 1999.
67. Ogawa, K., Asonuma, K., Inamoto, Y., Tabata, Y., and Tanaka, K. The efficacy of prevascularization by basic FGF for hepatocyte transplantation using polymer devices in rats. Cell Transplant. 10, 723, 2001.
68. Sakakibara, Y., Nishimura, K., Tambara, K., Yamamoto, M., Lu, F., Tabata, Y., and Komeda, M. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J. Thorac Cardiovasc. Surg. 124, 50, 2001.
69. 1 released from a biodegradable hydrogel. J. Control. Release 64, 133, 2000.
70. 1. Tissue Eng. 6, 331, 2000.
71. 1. J. Biomater. Sci. Polym. Ed. 11, 891, 2000.
72. Kimura, Y., Ozeki, M., Inamoto, T., Tabata, Y. Time course of de novo adipogenesis in matrigel by controlled release of basic fibroblast growth factor. Tiss. Eng. 8, 603, 2002.
73. Kimura, Y., Ozeki, M., Inamoto, T., Tabata, Y. Adipose tissue engineering based one human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 24, 2513, 2003.
74. Hong, L., Miyamoto, S., Yamada, K., et al. Enhanced formation of fibrosis in a rabbit aneurysm by gelatin hydrogel incorporating bFGF. Neurosurgery 49, 954, 2001.